On Thursday, The Medicines Company (NASDAQ:MDCO)’s shares inclined 1.07% to $43.31.
The Medicines Company (MDCO) declared that 18 presentations on its infectious disease programs will be presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the International Congress of Chemotherapy and Infection (ICC) joint meeting in San Diego, CA, September 17 to 21.
Company researchers will also report on the discovery of a new series of compounds (termed Broad-spectrum Carbapenemase Inhibitors, or BCIs) that have been shown in vitro to inhibit carbapenem-hydrolyzing beta-lactamase enzymes (carbapenemases) of both families (serine and metallo types) that are responsible for resistance to beta-lactam antibiotics.
The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
MRC Global Inc (NYSE:MRC)’s shares dropped -1.53% to $12.85.
MRC Global Inc. (MRC), the largest distributor of pipe, valves and fitting products and services to the energy industry, declared recently that it has initiated a rebranding of its global brands. As part of these rebranding efforts, the company has adopted a new logo to represent its global brand. While the company will continue to operate with sub-brands when appropriate, its primary identity will be the MRC Global brand.
This rebranding initiative will be executed in a phased approach across MRC Global’s operations. To ensure changes are implemented smoothly and efficiently, the company will communicate with employees, customers, suppliers and shareholders directly concerning any impact on their day-to-day business. More information about MRC Global’s sub-brands can be found on its website.
MRC Global Inc., through its auxiliaries, distributes pipes, valves, fittings, and related products and services to the energy and industrial sectors in the Unites States, Canada, and internationally.
At the end of Thursday’s trade, Forest City Enterprises, Inc. (NYSE:FCE.A)‘s shares surged 1.16% to $21.01.
Forest City Enterprises, Inc. (FCEA) declared that it had reached a contract and plan of merger (the “Merger Agreement”) by and among Forest City, Forest City Realty Trust, Inc. (“Forest City REIT”), FCILP, LLC (“FCILP”) and FCE Merger Sub, Inc. (“Merger Sub”), which was signed on September 15, 2015. As of the date of hereof, (i) Forest City REIT is a wholly-owned direct partner of Forest City incorporated under the laws of the state of Maryland, (ii) FCILP is a wholly-owned direct partner of Forest City REIT organized under the laws of the state of Delaware and (iii) Merger Sub is an Ohio corporation and is a wholly-owned partner of Forest City REIT owned in part directly and in part through Forest City REIT’s interest in FCILP.
As formerly revealed, the merger is just one step in a series of transactions that will result in Forest City’s conversion to real estate investment trust status commencing with the taxable year ending December 31, 2016. If the Merger is effected, Forest City will become a wholly owned partner of Forest City REIT, with Class A and Class B common stock of Forest City, being exchanged on a one-for-one basis for Class A and Class B shares, respectively, of Forest City REIT. Forest City shareholders will be asked to approve the Merger Agreement at a special meeting of shareholders to be held on October 22, 2015.
Forest City Enterprises, Inc. acquires, owns, develops, and manages commercial and residential real estate and land in the United States. The company’s Commercial group acquires, owns, develops, and operates regional malls, specialty/urban retail centers, office and life science buildings, and mixed-use projects, in addition to operates Barclays Center, a sports and entertainment arena located in Brooklyn, New York.
Liberty Global plc - Class C Common Shares (NASDAQ:LBTYK), ended its Thursday’s trading session with 1.86% gain, and closed at $45.40.
Leading international cable company Liberty Global plc has made a planned investment in Guavus, Inc., a provider of real-time big data analytics applications for operational intelligence.
Built on the proven Guavus Reflex ® operational intelligence platform, Guavus products allow cable operators to gain a holistic, cohesive view of network state and business context in real-time. It uniquely breaks down the barriers between Operational Support Systems and Business Support Systems to enable customers to more efficiently plan network capacity, improve service operations and deliver a better customer experience.
Guavus is committed to providing Multiple System Operators (MSOs) with analytics applications that break down silos of data and correlate network events with subscriber data for new innovative offerings. These big data applications provide the necessary operational intelligence to pinpoint network issues at a granular network level before they impact service levels.
Liberty Global plc, together with its auxiliaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, Puerto Rico, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
